phase readout
saveNCT07153796: A Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
ACTIVE_NOT_RECRUITINGupdated 51m ago
community read0 votes
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: B-cell Acute Lymphoblastic Leukemia
view source ↗
comments(0)
5-min edit window · permanent after that